HIV / AIDS in the News

Islatravir plus ulonivirine shows promise for weekly oral HIV treatment - Aidsmap

 

Pocan, Frankel, Randall, & Takano Lead 113 House Members in Letter to Omb Calling for Renewal of Community HIV Funds - Urban Milwaukee

 

International study shows once-weekly HIV pill performs as well as daily treatment - Medical Xpress

 

[AIDS 2026] WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs - European AIDS Treatment Group

 

Protecting Californians from HIV - UC Berkeley School of Public Health

 

AIDS 2026: Engineering adaptive NK cells against HIV - BioWorld News

 

Over 7,000 Young People Test HIV Positive In Karnataka: Why Colleges Are Being Targeted - Brut

 

Virginia funds more than $6 million to support HIV care, other services - WAVY.com

 

HIV prevention efforts continues despite latest funding barriers - Managed Healthcare Executive

 

Weekly Islatravir/Lenacapavir Combo Pill Maintains Viral Suppression - POZ

 

ViiV’s two-monthly HIV jab bests daily oral drugs in African teenagers - Yahoo

 

Islatravir Plus Ulonivirine Shows Promise as Weekly Oral Regimen - POZ

 

ViiV’s two-monthly HIV jab bests daily oral drugs in African teenagers - Clinical Trials Arena

 

Dolutegravir knocks down HIV faster than bictegravir - Aidsmap

 

Are 7,000 Karnataka students HIV-positive? Here's the truth - India Today

 

Thursday Shorts: HIV funding cuts, GLP-1s and absences, vaccine uncertainty, and vaccine legislation - Substack

 

Nine million people globally lack access to life-saving HIV treatment: WHO - The New Indian Express

 

Probiotic-derived bioactive metabolite reverses gut dysfunction and boosts HIV treatment response - UC Davis Health

 

Fiji Has The World’s Fastest Growing HIV Epidemic – And It Is Struggling - Health Policy Watch

 

Millions still get this wrong about HIV: Doctor explains exactly how the virus spreads, and how it doesn't - The Times of India

 

Islatravir-ulonivirine, another combination pill that could put HIV treatment on a weekly schedule | AIDS 2026 - Managed Healthcare Executive

 

Atlanta HIV rates remain unacceptably high amid federal funding shift - FOX 5 Atlanta

 

Atlanta HIV rates remain 'unacceptably high' amid federal funding shift - FOX 5 Atlanta

 

Adjusting To A Post-PEPFAR World - Health Policy Watch

 

Evolution of Biological Information: HIV Evolution - Science and Culture Today

 

[Press release] Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - eatg.org

 

[AIDS 2026] [Press release] ViiV Healthcare: New European, community co-created survey reveals strong interest in long-acting HIV treatment options but reported in-clinic conversations lag behind - European AIDS Treatment Group

 

AVAC: Innovation without access is injustice: AIDS 2026 opens in Rio - European AIDS Treatment Group

 

Weight-loss peptide only approved for use in HIV patients - AFP Fact Check

 

Macon town hall explains new Georgia HIV prevention law - 41NBC News